Primary Site >> Biliary tract Cancer
Gene >> BTC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Palliative and postoperative radiotherapy in biliary tract cancer. PMID: 12607581 |
Ref: Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma. PMID: 16342166 Ref: A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. PMID: 16475213 |
Ref: Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy. PMID: 17164111 Ref: HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer. PMID: 19262900 |
Ref: Systemic therapy for biliary tract cancers. PMID: 18448556 Ref: Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study. PMID: 19238628 |
Ref: Thymidylate synthase and dihydropyrimidine dehydrogenase are upregulated in pancreatic and biliary tract cancers. PMID: 19571608 Ref: Targeted therapy in biliary tract cancer: 2009 update. PMID: 20001803 |
Ref: Genetics of biliary tract cancers and emerging targeted therapies. PMID: 20547994 Ref: [Survival benefits of chemotherapy for unresectable biliary tract cancer--a multicenter retrospective analysis]. PMID: 21160263 |
Ref: Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities. PMID: 21274890 |
Ref: Expression and clinicopathological significance of notch signaling and cell-fate genes in biliary tract cancer. PMID: 21931375 Ref: Comparison of CT findings of biliary tract changes with autoimmune pancreatitis and extrahepatic bile duct cholangiocarcinoma. PMID: 22200917 Ref: Tumor growth effects of rapamycin on human biliary tract cancer cells. PMID: 22721369 |
Ref: State-of-the-art in the management of locally advanced and metastatic gallbladder cancer. PMID: 23635800 Ref: Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: a phase II-study (NCT00356161). PMID: 23927554 Ref: Novel diagnostic and prognostic biomarkers in biliary tract cancer. PMID: 23971898 |
Ref: Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway. PMID: 24002901 Ref: Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. PMID: 24351397 Ref: Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan. PMID: 24372748 Ref: Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer. PMID: 24630393 Ref: Adjuvant chemotherapy using gemcitabine for resected distal bile duct and ampullary cancers. PMID: 24901131 |
Ref: A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study. PMID: 25538178 Ref: Optimum chemotherapy for the management of advanced biliary tract cancer. PMID: 25892861 Ref: Genomic spectra of biliary tract cancer. PMID: 26258846 Ref: Predictive and prognostic molecular markers for cholangiocarcinoma in Han Chinese population. PMID: 26550313 |
Ref: Clinicopathological Features of Surgically-resected Biliary Tract Cancer Following Chemo-radiation Therapy. PMID: 26722062 Ref: Immunotherapy of biliary tract cancer. PMID: 26729196 Ref: Advances in biomarkers of biliary tract cancers. PMID: 27261586 Ref: Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing. PMID: 27267833 Ref: A case of advanced intrahepatic cholangiocarcinoma accidentally, but successfully, treated with capecitabine plus oxaliplatin (CAPOX) therapy combined with bevacizumab: a case report. PMID: 27342988 Ref: Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance. PMID: 27495988 Ref: Biliary cancer: Utility of next-generation sequencing for clinical management. PMID: 27622582 Ref: Progranulin as a predictive factor of response to chemotherapy in advanced biliary tract carcinoma. PMID: 27744566 Ref: Molecular profiling of biliary tract cancer: a target rich disease. PMID: 27747093 Ref: Surgical management of biliary tract cancers. PMID: 27829277 |
Ref: [Chemotherapy for Biliary Tract Cancer]. PMID: 28329919 Ref: Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer. PMID: 28529750 Ref: K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines. PMID: 28544747 Ref: Immunotherapeutic Approaches to Biliary Cancer. PMID: 28660602 Ref: Current biologics for treatment of biliary tract cancers. PMID: 28736630 Ref: [Biliary tract cancers : Molecular characterization and identification of novel prognostic markers]. PMID: 29063951 Ref: Successful radical surgical resection of initially unresectable intrahepatic cholangiocarcinoma by downsizing chemotherapy with gemcitabine plus cisplatin: a case report. PMID: 29164423 Ref: Metastasectomy for recurrent or metastatic biliary tract cancers: A single center experience. PMID: 29199665 |
Ref: A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer. PMID: 27849649 Ref: The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. PMID: 28841223 Ref: Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine. PMID: 29121415 Ref: Phase I Study of Chimeric Antigen Receptor-Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers. PMID: 29138340 Ref: Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome. PMID: 29238914 Ref: Family History of Cancer and Risk of Biliary Tract Cancers: Results from the Biliary Tract Cancers Pooling Project. PMID: 29339358 Ref: Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. PMID: 29360550 Ref: The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer. PMID: 29448202 Ref: Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study. PMID: 29527009 Ref: Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer. PMID: 29705976 Ref: Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival. PMID: 29765232 Ref: Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on estimates. PMID: 29777994 Ref: Biliary Tract Cancer: State of the Art and potential role of DNA Damage Repair. PMID: 30218788 Ref: Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes. PMID: 30325283 Ref: The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers. PMID: 30335866 Ref: Targeting phosphoinositide-3-kinase pathway in biliary tract cancers: A remedial route? PMID: 30370571 |